Abstract:The connection of two or more proteins with different binding specificities or activities can lead to unique and powerful systems with significant potential in therapeutic applications, particularly oncology. While a plethora of active bifunctional proteins have been produced by fusion, this approach is not always viable, since modification of the N- or C- terminus can compromise the proteins’ bioactivities, with complications during folding and processing often being observed. Chemical cross-linking can offer a more versatile strategy towards the synthesis of protein-protein conjugates. However, current state-of-the-art approaches are either not selective, yielding heterogeneous mixtures or require mutations with natural or unnatural amino acids, which are often associated with low expression yields and limited applicability towards all protein systems. Recently, a bis-dibromomaleimide cross-linking reagent was used to create a bispecific scFv-Fab antibody in a site-specific manner, by targeting and bridging disulfide bonds. In this work, the application of these cross-linking reagents was extended into the conjugation of proteins containing different reactive handles, as well as sterically hindered conjugation sites. Diiodo-maleimides were shown to offer the ideal properties of rapid bioconjugation and importantly, reduced hydrolysis, which was identified as a significant factor affecting the conjugation efficiency. The optimized linkers were exploited to link human serum albumin to antibody fragments (scFv and Fab) as a prospective half-life extension platform, with retention of antigen binding and robust serum stability. The linker design was also extended to incorporate a third point of attachment for another biomolecule. An anti-CEA scFv homotrimer was formed, by disulfide bridging, which was shown to infer a combination of greater antigen avidity and increased in vivo half-life. Finally, with the view to developing a Bispecific T-cell Engager (BiTE) construct that could lead to more efficient cell-killing, an anti-CEA/ anti-CD3 scFv heterotrimer of increased avidity towards CD3 antigen was developed, showing the potential of this strategy for the construction of a diverse range of bioconjugates. The last part of this thesis describes investigations towards the development of a new methodology that selectively modifies specific lysine residues, via acyl transfer from the disulfide bond of Fab antibody fragment. This approach is expected to complement disulfide bridging as a strategy for selective modification, but also be advantageous for systems where this could result in detrimental changes to the antibody structure, offering a highly promising platform for bioconjugation.

Identification of Styryl Sulfonyl Fluoride (SSF) as An Efficient, Robust and Irreversible Cysteine-specific Protein Bioconjugation Reagent

Identification of Styryl Sulfonyl Fluoride As a Near-Perfect Michael Acceptor for Diversified Protein Bioconjugations

Redox-Based Reagents for Chemoselective Methionine Bioconjugation

β-Carbonyl sulfonium enables cysteine-specific bioconjugation for activity-based protein profiling in live cells

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

A Sulfonium Tethered Peptide Ligand Rapidly and Selectively Modifies Protein Cysteine in Vicinity

Efficient site-specific labeling of proteins via cysteines

One Stone Two Birds: beta-Fluoropyrrolyl-Cysteine SNAr Chemistry Enabling Functional Porphyrin Bioconjugation

A method for selective 19 F-labeling absent of probe sequestration (SLAPS)

Site-Selective S-gem-Difluoroallylation of Unprotected Peptides with 3,3-Difluoroallyl Sulfonium Salts

Sulfoxide-mediated Cys-Trp-selective bioconjugation that enables protein labeling and peptide heterodimerization

Two Birds One Stone: Β-Fluoropyrrolyl-cysteine SNAr Chemistry Enabling Functional Porphyrin Bioconjugation

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking

Low-Toxicity Sulfonium-Based Probes for Cysteine-Specific Profiling in Live Cells

Enantioselective Synthesis of Chiral Sulfonimidoyl Fluorides Facilitates Stereospecific SuFEx Click Chemistry

Nucleophilic Covalent Ligand Discovery for the Cysteine Redoxome

Chemoselective and photocleavable cysteine modification of peptides and proteins using isoxazoliniums

Biocompatible SuFEx Click Chemistry: Thionyl Tetrafluoride (sof4)‐derived Connective Hubs for Bioconjugation to DNA and Proteins

Site-Specific Protein Modification By Genetic Encoded Disulfide Compatible Thiols

Sulfa-Michael Addition on Dehydroalanine: A Versatile Reaction for Protein Modifications

A Cysteine-specific Solubilizing Tag Strategy Enables Efficient Chemical Protein Synthesis of Difficult Targets